IRSA CFO updates equity and warrant holdings

IRSA Investments & Representations Inc CFO Matias Ivan Gaivironsky filed an amended Form 3 detailing his equity and derivative holdings.

Accepted by SEC EDGAR 03/19/2026 - 04:18 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

IRSA Investments & Representations Inc CFO Matias Ivan Gaivironsky filed an amended Form 3 detailing his equity and derivative holdings. He directly holds 229,787 common shares and 9,817 ADS. He also holds restricted share units tied to 215,111 underlying common shares granted on March 17, 2026, which are scheduled to vest in two tranches of 107,555 common shares in January 2027 and 107,556 common shares in January 2028. In addition, he holds warrants linked to 130,018 underlying common shares, with each warrant giving the option to acquire 1,6367 common shares at a price of USD 0,2641 per common share, exercisable through May 12, 2026.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Gaivironsky Matias Ivan

Role CFO

Type	Security	Shares	Price	Value
Holding	Restricted Shares Unit (RSU)	--	--	--
Holding	Warrants	--	--	--
Holding	ADS	--	--	--
Holding	Common Shares	--	--	--

Holdings: Restricted Shares Unit (RSU) — 215,111 contracts (Direct); Warrants — 130,018 contracts (Direct); ADS — 9,817 shares (Direct); Common Shares — 229,787 shares (Direct)

Footnotes (2)

1. F1. These restricted shares units were granted on March 17, 2026 and will vest 107555 common shares on January 2027 and 107556 common shares on January 2028.
2. F2. Each warrant give the option to acquire 1,6367 common shares at a price of usd 0,2641 per common share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does IRSA (IRS) CFO Matias Gaivironsky report in this amended Form 3?

The filing shows CFO Matias Ivan Gaivironsky’s direct ownership in IRSA, including common shares, ADS, restricted share units, and warrants. It outlines current holdings and vesting schedules, rather than new market transactions or trades in the company’s securities.

How many IRSA (IRS) common shares does the CFO directly own?

The CFO is reported as directly holding 229,787 common shares of IRSA. This position is separate from his derivative interests, such as restricted share units and warrants, which are tied to additional underlying common shares that may convert in the future.

What restricted share units does the IRSA (IRS) CFO hold and when do they vest?

The CFO holds restricted share units linked to 215,111 underlying common shares. According to the filing, they were granted on March 17, 2026 and are scheduled to vest 107,555 common shares in January 2027 and 107,556 common shares in January 2028.

What warrants related to IRSA (IRS) common shares are disclosed for the CFO?

The filing lists warrants tied to 130,018 underlying common shares. Each warrant gives the option to acquire 1,6367 common shares at a price of USD 0,2641 per common share, with an exercise and expiration date of May 12, 2026.

Does the IRSA (IRS) CFO hold any ADS according to this Form 3/A?

Yes. The amended Form 3 reports that the CFO directly holds 9,817 ADS. These American Depositary Shares represent another form of equity interest in IRSA in addition to his common shares and derivative-based holdings disclosed in the filing.

Is this IRSA (IRS) Form 3/A about new insider buying or selling?

The document primarily details existing holdings of the CFO, including shares, ADS, restricted share units, and warrants. The transaction summary shows holding entries with unknown transaction codes, rather than clear open-market purchases or sales of IRSA securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gaivironsky Matias Ivan

(Last) (First) (Middle)

CARLOS DELLA PAOLERA 261, 9TH FLOOR

(Street)

BUENOS AIRES C1001ADA

(City) (State) (Zip)

ARGENTINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/19/2026

3. Issuer Name and Ticker or Trading Symbol
IRSA INVESTMENTS & REPRESENTATIONS INC [ IRS ]

3a. Foreign Trading Symbol
[IRSA]

5. If Amendment, Date of Original Filed (Month/Day/Year)
03/18/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
ADS	9,817	D
Common Shares	229,787	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Shares Unit (RSU)	(1)	(1)	Common Shares	215,111	(1)	D
Warrants	05/12/2026	05/12/2026	Common Shares	130,018	$0.2641(2)	D

Explanation of Responses:

1. These restricted shares units were granted on March 17, 2026 and will vest 107555 common shares on January 2027 and 107556 common shares on January 2028.

2. Each warrant give the option to acquire 1,6367 common shares at a price of usd 0,2641 per common share.

	Amalia Cristina Sternheim as Attorney-in-Fact for Matias Ivan Gaivironsky	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)